Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Curis Inc.

Start price
Target price
Perf. (%)
€6.35
13.12.20
-
13.12.21
37.01%
16.02.21

Below average Marketposition
Probably not worthwhile Investment
Significant cyclical dependencies
Little known brand
Lexicon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.66
13.12.20
-
13.12.21
143.95%
16.02.21

Probably not worthwhile Investment
Significant cyclical dependencies
Inovio Pharma

Start price
Target price
Perf. (%)
€9.35
10.12.20
€7.00
10.12.21
20.86%
20.02.21

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Curis Inc.

Start price
Target price
Perf. (%)
€5.90
09.12.20
€4.00
7.63%
14.12.20

Risky Investment
Lexicon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.56
08.12.20
-
6.64%
10.12.20

Risky Investment
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€5.51
07.12.20
€25.00
07.12.21
93.92%
08.12.21

Could be very worthwhile Investment >20% year
buy
Trevena Inc.

Start price
Target price
Perf. (%)
€49.08
04.12.20
€55.00
28.04.21
23.84%
09.02.21

Could be very worthwhile Investment >20% year
buy
Corbus Pharmaceuticals Holding Inc.

Start price
Target price
Perf. (%)
€46.50
01.12.20
€90.00
01.12.21
-27.97%
14.12.20

Could be worthwhile Investment >10% per year
Very bad culture
No uniques
Below average Management
buy
Genmark Diagnostics

Start price
Target price
Perf. (%)
€11.10
30.11.20
€14.00
30.11.21
-7.21%
14.12.20

Could be worthwhile Investment >10% per year
buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€13.50
30.11.20
€15.00
30.11.21
31.85%
14.12.20

Could be worthwhile Investment >10% per year
buy
Cutera Inc.

Start price
Target price
Perf. (%)
€21.00
30.11.20
€25.00
30.11.21
-15.71%
14.12.20

Could be worthwhile Investment >10% per year
buy
CHF Solutions Inc

Start price
Target price
Perf. (%)
-
30.11.20
€7.00
30.11.21
-
14.12.20

Could be very worthwhile Investment >20% year
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€10.60
29.11.20
€12.00
29.11.21
-11.79%
10.12.20

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€19.50
28.11.20
€23.00
28.11.21
-36.41%
01.11.21

Could be worthwhile Investment >10% per year
Inovio Pharma

Start price
Target price
Perf. (%)
€8.95
21.11.20
-
21.11.21
28.49%
10.02.21

Could be worthwhile Investment >10% per year
High risks for its business
Dependend from few customers or products
buy
Genmark Diagnostics

Start price
Target price
Perf. (%)
€11.50
16.11.20
€13.00
16.11.21
-3.48%
30.11.20

Could be worthwhile Investment >10% per year
buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€13.20
16.11.20
€15.00
16.11.21
2.27%
30.11.20

Could be worthwhile Investment >10% per year
buy
Cutera Inc.

Start price
Target price
Perf. (%)
€18.10
16.11.20
€20.00
16.11.21
16.02%
30.11.20

Could be worthwhile Investment >10% per year
buy
CHF Solutions Inc

Start price
Target price
Perf. (%)
-
16.11.20
€7.00
16.11.21
-
30.11.20

Could be very worthwhile Investment >20% year
Bellicum Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.30
07.11.20
-
07.11.21
15.65%
15.07.21

Probably not worthwhile Investment
buy
Misonix Inc.

Start price
Target price
Perf. (%)
€9.55
02.11.20
€11.00
04.11.21
4.19%
16.11.20

Could be worthwhile Investment >10% per year
buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€11.40
02.11.20
€13.00
04.11.21
15.79%
16.11.20

Could be worthwhile Investment >10% per year
buy
Genmark Diagnostics

Start price
Target price
Perf. (%)
€10.90
02.11.20
€13.00
04.11.21
5.50%
16.11.20

Could be worthwhile Investment >10% per year
buy
CHF Solutions Inc

Start price
Target price
Perf. (%)
-
02.11.20
€8.00
04.11.21
-
16.11.20

Could be very worthwhile Investment >20% year
buy
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.15
02.11.20
€13.00
04.11.21
-4.96%
05.11.21

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation